The study found that Prequel ® Prenatal Screen with AMPLIFY™ technology enables reliable results as early as eight-weeks’ gestation. Typically, prenatal cell-free DNA (pcfDNA) screening is offered ...
Placenta accreta spectrum (PAS) disorders are a group of conditions characterized by abnormal attachment of the placenta to the uterine wall. This can range from a superficial attachment to deeper ...
Placental growth factor, a blood-based protein, may be a reliable method to detect abnormalities in the brain that presage cognitive impairment indicative of Alzheimer’s disease, data show.